MIS-C and Visceral Leishmaniasis Co-occurence: Has the Clinic of Other Diseases Masked in the Pandemia? MIS-C ve Visseral Leishmaniasis Birlikteliği: Pandemide Diğer Hastalıkların Kliniği Maskelendi mi?
Turkiye Parazitoloji Dergisi, cilt.46, sa.3, ss.242-245, 2022 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 46 Sayı: 3
- Basım Tarihi: 2022
- Doi Numarası: 10.4274/tpd.galenos.2022.28290
- Dergi Adı: Turkiye Parazitoloji Dergisi
- Derginin Tarandığı İndeksler: Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.242-245
- Anahtar Kelimeler: Child, multisystem inflammatory syndrome, SARS-CoV-2, visceral leishmaniasis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
At the end of 2019, the newly detected severe acute respiratory syndrome-coronavirus (COVID)-2 in China spread rapidly and caused a global epidemic. It has been observed that the virus, which is the cause of COVID-2019 and can cause severe acute respiratory failure, later causes a hyperinflammatory picture and causes a clinical picture similar to Kawasaki disease. Fever, cardiac involvement and rash are the most common findings in this picture, which is called multisystem inflammatory syndrome (MIS-C). Although its pathophysiology is not fully known yet, the most common cause is thought to be post-infection immune dysregulation. Visceral leishmaniasis (VL) is a zoonosis in which Leishmania infantum and rarely Leishmania donovani are the agents and can cause a similar clinical picture. In this text; we discussed a patient who was followed up with a diagnosis of COVID-associated MIS-C, but without an adequate response in his clinic with MIS-C treatment, and was diagnosed with VL with further examinations. To our knowledge, this is the first MIS-C and VL co-occurence in the literature.